BOSTON, Aug. 31 (UPI) -- Two U.S. studies say Pfizer's painkiller Celebrex can slow the recurrence of polyps in the colon for those at a higher risk of developing colon cancer.

Dr. Robert L. Barkin, Associate Professor at Rush University Medical Center in the departments of Anesthesiology, Family Medicine, Pharmacology, and Clinical Pharmacologist for the Rush Pain Center of Chicago and the Northshore Pain Center of Skokie, IL, will make two key presentations at the Opioid Education Program to be held at Northwestern University September 16 and 17.

By Julie Schmit Two years after safety concerns bloodied and bruised the arthritis painkiller market, Pfizer's Celebrex is making a comeback. Annual sales are expected to top $2 billion this year after falling to $1.7 billion last year. Sales were at $3.3 billion in 2004.

Research has long suggested that the popular pain reliever Celebrex might prevent colorectal polyps, which can lead to cancer.

Research has long suggested that the popular pain reliever Celebrex might prevent colorectal polyps, which can lead to cancer.

Testing revealed fake versions of Lipitor and other widely used prescription drugs ordered through Web sites linked to a Canadian pharmacy, the Food and Drug Administration said Wednesday.

Devices to stimulate the brain work better than drugs alone at easing tremors in patients with advanced Parkinson's disease, researchers report.

Researchers report progress toward development of a drug to treat measles, which remains one of the world's most devastating infectious diseases despite availability of a vaccine to prevent it.

ENGLEWOOD CLIFFS, N.J., Aug. 30 /PRNewswire-FirstCall/ -- EpiCept Corporation ( Nachrichten ) (Nasdaq: EPCT; Stockholm: EPCT) announced today that it has successfully closed a $10 million senior secured term loan with Hercules Technology Growth Capital, Inc. . The funds will be used to advance the company's pipeline, including Ceplene(TM), its lead oncology compound for the treatment of Acute

An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.